Central Government Expands Control Over Narcotic Drugs and Psychotropic Substances

The Ministry of Finance, Department of Revenue, issued three significant notifications on February 8, 2024, which came into force upon their publication in the Gazette of India on February 9, 2024. These notifications collectively expand the scope of the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985), by bringing several new synthetic substances under its regulatory framework. The Central Government, exercising powers conferred by the Act, declared four specific substances as "manufactured drugs" (drugs derived from opium, coca leaf, or other narcotic substances, or synthetic drugs declared as such) and added three others to the Schedule of "psychotropic substances" (substances that affect the mind or behavior, listed in the Schedule to the NDPS Act). Concurrently, the notifications also established the "small and commercial quantities" (thresholds determining the severity of penalties under the NDPS Act) for all these newly controlled compounds.

Notification S.O. 577(E) specifically identified and declared 2-Methyl-AP-237, Etazene, Etonitazepine, and Protonitazene, along with their salts and preparations, as manufactured drugs under sub-clause (b) of clause (xi) of section 2 of the NDPS Act. These substances are synthetic opioids known for their high potency and abuse potential. Following this, Notification S.O. 578(E) amended the Schedule to the NDPS Act by inserting three new entries after serial number 110ZZB. These additions include ADB-BUTINACA, Alpha-PiHP, and 3-Methylmethcathinone, which are now classified as psychotropic substances. The Central Government's decision to include these substances was based on available information and evidence regarding their nature, effect, and scope for abuse, as well as modifications incorporated into the United Nations Convention on Psychotropic Substances, 1971. Finally, Notification S.O. 579(E) amended a prior notification, S.O. 1055 (E) dated October 19, 2001, to prescribe the small and commercial quantities for all seven newly controlled substances, ranging from 0.0005 grams (small quantity for Etonitazepine) to 375 grams (commercial quantity for 3-Methylmethcathinone). This ensures that possession, consumption, or trafficking of these substances above the specified limits will attract penalties under the NDPS Act, affecting individuals and entities involved in such activities, as well as law enforcement agencies.

The legislative intent behind these notifications is to proactively address the emergence of new synthetic drugs that pose significant public health and safety risks. The policy rationale is rooted in the need to prevent the illicit manufacture, possession, sale, and consumption of these potent substances, which were previously not explicitly covered by the existing legal framework. The earlier legal position presented a statutory gap where these novel psychoactive substances could be trafficked and abused without immediate legal recourse under the NDPS Act. By declaring them as manufactured drugs or adding them to the list of psychotropic substances, the Central Government aims to close these loopholes. The legislation provided: “Whereas the Central Government is satisfied, on the basis of information and evidence which has become available to it, with respect to the nature and effect of and the scope for abuse of the following substances (natural or synthetic) or natural material or any salt or preparation of such substances or materials, and the modification with respect to such substances and the changes that have been incorporated in the United Nations Convention on Psychotropic Substances, 1971, that it is necessary to add the following substances or natural materials or salts or preparation of such substances or materials in the list of psychotropic substances specified in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985)...” This statement underscores the government's commitment to adapting its drug control policies to evolving threats, particularly those identified through international conventions. The amendments introduce new obligations for individuals and entities to comply with the stringent regulations of the NDPS Act concerning these substances. The establishment of small and commercial quantities provides clear enforcement mechanisms, enabling law enforcement agencies to prosecute offenders effectively based on the quantity of the substance involved, thereby ensuring a graded response to drug-related offenses. These measures are crucial for safeguarding public health and maintaining social order by bringing these dangerous compounds under strict legal control.

Keywords: Narcotic Drugs, Psychotropic Substances, NDPS Act, Manufactured Drugs, Synthetic Drugs, Drug Control, India, Ministry of Finance, Notification Geo Tags: India District: Not Applicable